Nepedia
Back to Discover
Advanced Reader
🧬

Lactococcus lactis

life science Maturity 11-13 Next article →

Lactococcus lactis is a gram-positive bacterium that plays a vital role in both the food industry and modern medicine. It is a coccus, which means it is shaped like a small sphere. These cells often group together in pairs or short chains. They are nonmotile, so they cannot move on their own, and they are nonsporulating, meaning they do not produce spores. Most L. lactis cells are between 0.5 and 1.5 micrometers in length. This microbe is essential for producing dairy items like buttermilk and many types of cheese. It is also famous for being the first genetically modified organism used alive to treat human disease.

The bacterium functions through a process called homofermentative metabolism. This means it converts sugars into lactic acid to produce energy. When L. lactis is added to milk, it uses enzymes to break down a sugar called lactose. This process creates energy molecules known as ATP. A byproduct of this energy production is lactic acid. The lactic acid causes the milk to curdle, which separates the liquid from solid clumps called curds. These curds are then used to manufacture various cheeses. This metabolic process is a cornerstone of the global dairy industry.

L. lactis is used to create many specific types of cheese. The subspecies L. lactis subsp. lactis is used in the early stages of making Brie, Camembert, and Cheddar. It is also used for Colby, Gruyère, Parmesan, and Roquefort. Beyond dairy, this bacterium is involved in the fermentation of other foods. It can be used to produce pickled vegetables, beer, wine, and certain breads. It is even used in fermented products like soymilk kefir. Because of its long history in food, it has generally recognized as safe (GRAS) status.

Scientists have studied how L. lactis evolved from living on plants to living in dairy. Most isolates come from either plant material or dairy environments. It is suggested that dairy bacteria evolved from plant isolates through genome erosion. This is a process of reductive evolution where genes that are not useful in milk are lost or downregulated. In laboratory experiments, researchers grew plant isolates in milk for long periods. This resulted in the loss of unnecessary genes and the upregulation of peptide transport. This shows how the bacteria adapted to the nutrient-rich environment of milk.

In the dairy industry, L. lactis faces challenges from bacteriophages. These are viruses that infect bacteria and can cause significant economic losses. These phages prevent the bacteria from fully metabolizing the milk substrate. The most responsible species belong to the family Siphoviridae, specifically types 936, c2, and P335. Despite these challenges, the bacterium is culturally significant. In 2010, the Wisconsin State Assembly passed a bill to name L. lactis the official state microbe. The bill was introduced in November 2009 by several representatives. However, the legislation was dropped by the Senate on April 28, 2010.

Medical research has turned L. lactis into a tool for delivering functional proteins. Because it is noninvasive and nonpathogenic, it is a promising candidate for protein delivery. One major area of study is treating inflammatory bowel diseases (IBD). Scientists have engineered L. lactis to secrete a cytokine called interleukin-10 (IL-10). This protein helps downregulate inflammatory cascades in the body. The bacteria can deliver this protein to the intestinal epithelium or through M cells into lymphoid tissue. This method may be an alternative to systemic treatments that are difficult to produce.

L. lactis is also being studied for its ability to fight cancer. Researchers created a strain, L. lactis NZ9000, that carries a plasmid with a peptide called KISS1. This peptide helps inhibit tumor metastasis, which is the spread of cancer. The secreted KISS1 protein can downregulate the expression of Matrix metalloproteinases (MMP-9). This enzyme is a key factor in how cancer cells invade and grow. By activating specific signaling pathways, the engineered bacteria can reduce cancer cell survival and induce dormancy. This makes L. lactis a potential new tool for future cancer therapies.

666 words

Where will your curiosity go next?

Keep exploring at your chosen reading level.

More to explore

What is Nepedia?

A free, ad-free encyclopedia for children. Every article is written at five reading levels, so the same page works for a five-year-old and a fifteen-year-old — use the level switcher above to see this one change. No account needed to read.